Delivery Order SPE2DB22D1017-SPE2DB23FF5SK
- Not listed
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Cyclosporine 0.05% Eye Emulsion, a specialty medication used in the treatment of eye conditions. The contract has a ceiling value of $2,652.78 and an ultimate completion date of June 14, 2024. The contract is a Firm Fixed Price type, with no set-aside designation....
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,758.35 firm fixed-price delivery order is for the supply of Cyclosporine 0.05% eye emulsion, with an ultimate completion date of November 1, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cyclosporine 0.05% eye emulsion. The contract, which is a firm fixed-price delivery order, has a ceiling value of $1,465.16 and a completion date of July 10, 2025. The contract is not set aside and is an open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cyclosporine 0.05% eye emulsion. The $2,181.63 contract has an ultimate completion date of December 5, 2022 and is part of AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a wide range of pharmaceuticals and medical supplies to support military...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,925,986 units of Cyclosporine 0.05% eye emulsion in 30-count packages, with a ceiling value of $1,083.84. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 16, 2025. Amerisourcebergen Drug Corp holds a significant...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Cyclosporine 0.05% eye emulsion, a critical ophthalmic medication, to support military treatment facilities and other government healthcare programs. The contract has a firm fixed price of $2,991.65 and runs through September 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Cyclosporine 0.05% eye emulsion. The contract has a ceiling value of $4,432.37 and a completion date of October 11, 2024. The order is a firm fixed-price contract and is not set aside for any specific business category. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which is part of a larger Indefinite Delivery Contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Cyclosporine 0.05% Eye Emulsion, with a ceiling value of $1,161.69 and a performance period ending on June 13, 2025. The contract is a firm-fixed-price delivery order, without a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cyclosporine 0.05% eye emulsion. The contract is a firm-fixed-price delivery order worth $2,969.72, with a period of performance through September 27, 2024. AmerisourceBergen is the prime contractor and there is no set-aside designation mentioned. This order is likely part of a larger Indefinite Delivery Contract (IDC) between...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of 4,565,441,778 units of Cyclosporine 0.05% Eye Emulsion in 60-count packages, with a ceiling value of $2,544.21 and an ultimate completion date of August 14, 2024. This award is not designated as a set-aside contract. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB23FF5SKDelivery Order
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Cyclosporine 0.05% eye emulsion, a medication used to treat certain eye conditions. The award has a ceiling value of $2,972.19 and an ultimate completion date of April 19, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is not designated with a set-aside requirement, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 4/18/23 |